Development of antiviral peptides as potential therapeutic drugs for COVID-19

With the rapid spread of severe acute respiratory syndrome coronavirus-2 (SARS -CoV -2) . the respiratory syndrome that it caused has become a pandemic. The World Health Organization officially named COVID-19 on 11 February 2020. COVID-19 has wrought havoc on everyday life and healthcare systems. and development of new antiviral drugs to treat it is an important issue. Many anti-viral peptides (AVPs) have been reported to have good activity. Here, we summarize the process of SARS-CoV-2 infection and the potential application of AVPs to provide new ideas for the development of new antiviral drugs.